Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...

Eric Swayze, Executive Vice President of Research at Ionis Pharmaceuticals Inc. (NASDAQ:IONS), a $5 billion market cap ...

These transactions were part of a routine process involving automatic sales to cover tax obligations related to restricted stock units. After these transactions, Devers holds 15,937 shares of Ionis ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Kennedy, who suspended his independent bid for the presidency to endorse Trump immediately following the Democratic National ...

The Federal Trade Commission on Friday said it has reached a settlement with Welsh, Carson, Anderson & Stowe and its ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...